Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticancer drugs: second malignancies--risk reduction

E Petru1, D Schmähl

  • 1Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, F.R.G.

Cancer Treatment Reviews
|December 1, 1987
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.

Gynecologic oncology·2006
Same author

Re: "Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy".

Gynecologic oncology·2005
Same author

[Wound rupture after Misgav-Ladach cesarean section: a case report].

Gynakologisch-geburtshilfliche Rundschau·2004
Same author

Palliative cytostatic treatment of cervical carcinoma.

European journal of gynaecological oncology·2003
Same author

Vesicocutaneous fistula mimicking an abdominal wall abscess 2 years after radical abdominal hysterectomy.

Gynecologic oncology·2003
Same author

Can bowel endoscopy predict colorectal surgery in patients with an adnexal mass?

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026
Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026
Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026
Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026
Same journal

Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.

Cancer treatment reviews·2026
See all related articles